Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460

Watchlist Manager
Sihuan Pharmaceutical Holdings Group Ltd Logo
Sihuan Pharmaceutical Holdings Group Ltd
HKEX:460
Watchlist
Price: 0.72 HKD 1.41%
Market Cap: 6.7B HKD
Have any thoughts about
Sihuan Pharmaceutical Holdings Group Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

98.5
Current
6
Median
13.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
98.5
=
Enterprise Value
3B HKD
/
EBITDA
28.1m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-4.7
2-Years Forward
EV/EBITDA
-7.2
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More